Furthermore, active known or suspected autoimmune conditions were excluded, with the exception of those requiring an external trigger, adequately managed conditions associated with prior anti-PD-1 or anti-programmed cell death ligand 1 (PD-L1) treatment, or non-relevant conditions such as vitiligo or type 1 diabetes. This evidence concerns the gene CD274 and vitiligo.